Tokyo, Japan

Momoko Otaki

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Japan Blood Products Organization. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Momoko Otaki. Retrieved from https://idiyas.com/inventor/momoko-otaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Momoko Otaki: Innovator in Recombinant Fibrinogen Production

Introduction

Momoko Otaki is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the production of recombinant fibrinogen. Her innovative work has the potential to impact various medical applications.

Latest Patents

Momoko Otaki holds a patent for a "Recombinant fibrinogen high-production line and method for producing same." This invention provides a recombinant strain that highly produces fibrinogen, which is crucial for blood clotting. The patent details a method involving the coexpression of fibrinogen and α2PI and/or PAI-2 in an animal cell strain. The process includes introducing specific genes into the animal cell and culturing the recombinant strain to recover fibrinogen from the culture.

Career Highlights

Momoko Otaki is affiliated with the Japan Blood Products Organization, where she continues to advance her research and development efforts. Her work is instrumental in enhancing the production methods of vital blood components.

Collaborations

She collaborates with notable colleagues, including Shusei Uno and Kouji Murakami, who contribute to her research initiatives and projects.

Conclusion

Momoko Otaki's innovative contributions to recombinant fibrinogen production exemplify her dedication to advancing biotechnology. Her work not only showcases her expertise but also holds promise for future medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…